Trial Profile
An International, Open, Randomized, Controlled Study to Evaluate the Efficacy of Combining Prophylactic Curosurf® With Early Nasal CPAP Versus Early Nasal CPAP Alone in Very Preterm Infants at Risk of Respiratory Distress Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2018
Price :
$35
*
At a glance
- Drugs Poractant alfa (Primary)
- Indications Respiratory distress syndrome
- Focus Therapeutic Use
- Acronyms Curpap
- Sponsors Chiesi Farmaceutici
- 25 Mar 2015 New trial record